Pricing Log in Create free account
Friday 6 November 2026 Export AVAH’s income statement to Excel — free account

Aveanna Healthcare Holdings Inc.

AVAH Healthcare Medical Care Facilities

Aveanna Healthcare Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 20.2% from fiscal 2024.

Revenue
+13.7%
EPS
+46.2%
Free cash flow
+57.9%
Total debt
+1.07%

Quarter to June 2026, against a year earlier

13.68 0.55 −3.87%
Market cap
$3.0B
P/E
10.5×
Fwd P/E
18.3×
Dividend yield
—
F-score
7/9
Altman Z
1.45
Beneish M
−2.10
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 781.63
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell 5 — 5 — — 1 9 — 6 — — —
Insider Ownership 46.89%

Capital & Financial Ratios $m

Size
Market Cap 2,980.00
Revenue ttm 2,602.82
Net income ttm 274.76
Free cash flow ttm 158.38
Net debt Q 1,365.69
Valuation
P/E 10.52
Forward P/E 18.30
Price / sales 1.14
Forward P/S Powerpack
Price / FCF 18.81
Price / book 10.37 (above 6: high)
Financial health
Current ratio Q 1.16
Debt / equity Q 5.09 (above 2: weak)
Interest coverage Q 2.88
Growth
Revenue growth Q +13.73% (above 0%: growing)
Operating income growth Q −0.07% (below 0%: shrinking)
EPS, this year +37.41% (at or above 15%: strong)
EPS, next year A +10.04%
Revenue, next year A +10.68% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +18.75% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.7×, against a ten-year median of 1.1×; over the ten years it ranged from 0.9× in 2022 to 1.8× in 2021.
P/S against its own 10 years 97.55%
10-year low 10-year high
EV/Sales against its own 10 years 95.82%
10-year low 10-year high
EV/FCF against its own 10 years 25.97%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 44 84 193 97
Receivables 246 278 316 341
Inventory — — — —
Other 9 13 30 18
315 393 560 478
2023 2024 2025 Q'26
Payables 30 36 32 32
ST’ Debt 164 178 178 178
Other 78 85 90 86
355 402 424 411

Compound Annual Growth %

10y 5y 3y
Sales — 10.23% 10.82%
Cash Flow — 1.54% 0.00%
Earnings — 0.00% 0.00%
Book Value — (6.00%) 0.00%

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.17 Actual 0.22

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.08 0.15 Beat by 0.07
Q4 FY26 0.12 0.17 Beat by 0.05
Q1 FY26 0.13 0.18 Beat by 0.05
Q2 FY26 0.17 0.22 Beat by 0.05
Q3 FY26 0.20 — Reports 12 November 2026

EPS $

Mar Jun Sep Dec Year
’26 0.19 0.18 — — —
’25 0.03 0.13 0.06 0.80 1.05
’24 (0.06) 0.07 (0.22) 0.14 (0.06)
’23 (0.17) 0.13 (0.54) (0.13) (0.71)
’22 0.14 (2.56) 0.13 (1.28) (3.57)
’21 0.04 0.01 0.01 (0.68) (0.69)
’20 0.27 (0.55) (0.05) (0.07) (0.40)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 648 670 — — —
’25 559 590 622 662 2,433
’24 491 505 509 520 2,025
’23 466 472 478 479 1,895
’22 451 443 443 451 1,788
’21 417 436 411 414 1,679
’20 355 352 366 422 1,495
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 81 — — —
’25 (9) 52 33 50 126
’24 (12) 2 29 13 33
’23 7 (11) 29 (3) 23
’22 (9) (20) 21 (40) (48)
’21 (33) 19 36 (34) (11)
’20 44 33 42 (1) 117
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 0 80 — — —
’25 (11) 50 31 48 118
’24 (13) 1 27 12 26
’23 5 (12) 28 (5) 17
’22 (13) (22) 18 (43) (60)
’21 (36) 16 32 (39) (27)
’20 38 28 40 (5) 101
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.6
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — 1,254 1,384 1,495 1,679 1,788 1,895 2,025 2,433 2,603 +9.9% 2,693 2,899 3,069 +8.0%
Gross margin, % — — 30.46 30.29 30.40 32.31 30.95 31.42 31.39 33.31 32.28 +2.9 pt
EBT — — (50) (75) (52) (114) (664) (139) 5 107 154 n/m
EBT margin, % — — (3.99) (5.42) (3.46) (6.77) (37.13) (7.33) 0.25 4.40 5.92 +8.4 pt
Net income — 0 (47) (77) (57) (117) (662) (135) (11) 225 275 n/m
Per share, $
Per share, $ Revenue — — 6.74 10.11 10.61 9.84 9.63 9.98 10.50 11.96 11.95 +8.5%
Earnings — — (0.25) (0.56) (0.40) (0.69) (3.57) (0.71) (0.06) 1.11 1.30 n/m
Cash flow — — 0.12 (0.06) 0.83 (0.07) (0.26) 0.12 0.17 0.62 0.77 +27.0%
Capex — — 0.00 (0.12) (0.11) (0.09) (0.06) (0.03) (0.03) (0.04) (0.05) n/m
Free cash flow — — 0.12 (0.19) 0.72 (0.16) (0.33) 0.09 0.14 0.58 0.73 +25.9%
Book value — — 1.85 0.00 1.88 3.73 (0.03) (0.68) (0.64) 0.96 1.32 (9.0%)
Shares, m — — 186 137 141 171 186 190 193 204 211 +1.3%
Valuation, ×
Valuation, × P/E — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.56 10.52 0.9
P/S — — 1.10 1.10 1.10 0.75 0.07 0.28 0.44 0.68 1.14 0.7
P/B — — 6.28 6.28 6.28 1.99 0.00 0.00 0.00 8.55 10.37 3.7
EV/Sales — — 1.81 1.81 1.81 1.54 0.86 1.01 1.11 1.21 1.67 1.4
EV/FCF — — 100.12 100.12 100.12 (94.77) (25.54) 116.02 85.37 24.78 27.43 50.8
Cash, $m
Cash, $m Operating cash flow — — 22 (9) 117 (11) (48) 23 33 126 168 +28.6%
Capex — — (20) (17) (15) (16) (12) (6) (6) (7) (10) (12.9%)
Free cash flow — — 22 (25) 101 (27) (60) 17 26 118 158 +27.5%
Balance, $m
Balance, $m Working capital — — 17 17 80 (66) (57) (40) (9) 136 67 +34.6%
Net debt — — 944 1,080 1,036 1,325 1,411 1,397 1,365 1,272 1,366 +4.3%
Shareholders’ equity — — 345 — 265 636 (6) (130) (124) 194 287 (7.9%)
Returns, %
Returns, % ROA — — (6.06) (9.87) (3.36) (5.60) (32.72) (8.09) (0.67) 12.24 14.17 +18.3 pt
ROIC — — 0.00 2.25 (0.17) (1.15) (28.58) 0.40 7.04 10.93 10.36 +10.9 pt
ROE — — (15.28) (24.88) (21.33) (25.99) (210.33) 198.00 8.64 634.70 199.62 +650.0 pt
People
People Employees — — — — 42,000 33,000 3,700 33,500 33,500 35,500 — (3.3%)
Revenue/emp, $m — — 0.00 0.00 0.04 0.05 0.48 0.06 0.06 0.07 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Aveanna Healthcare Holdings Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
OPCH Option Care Health, Inc. $4.7B 22.6× 21.2× +4.08% (above 0%: growing) +19.81% (above 0%: growing) −17.04% (below 0%: shrinking) 19.08% 5.97% Compare
NHC National HealthCare Corporation $3.3B 28.2× 8.4× +6.61% (above 0%: growing) −65.61% (below 0%: shrinking) +75.52% (above 0%: growing) 100.00% 0.00% Compare
ACHC Acadia Healthcare Company, Inc. $3.2B — (loss-making) 34.4× +5.14% (above 0%: growing) −5.00% (below 0%: shrinking) +196.54% (above 0%: growing) 100.00% 0.00% Compare
SGRY Surgery Partners, Inc. $3.0B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
AVAH Aveanna Healthcare Holdings Inc. $3.0B 10.5× 18.3× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93%
BKD Brookdale Senior Living Inc. $2.6B — (loss-making) 341× −11.61% (below 0%: shrinking) n/m +533.14% (above 0%: growing) 29.94% 11.86% Compare
GRDN Guardian Pharmacy Services, Inc. $2.5B 37.8× 33.3× −1.68% (below 0%: shrinking) +133.33% (above 0%: growing) +88.88% (above 0%: growing) 22.97% 6.75% Compare
MD Pediatrix Medical Group, Inc. $2.5B 17.1× 15.3× +1.72% (above 0%: growing) −27.61% (below 0%: shrinking) −14.41% (below 0%: shrinking) 27.98% 13.01% Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −17.07% (below 0%: shrinking) 32.08% 10.27% Compare
Median of peers $2.8B 22.6× 21.2× +3.42% +7.41% +30.56% 28.96% 8.51%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 17 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2026 4.86m 17.89m 1,035.90
2024 4.54m 10.56m 597.44
2023 2.91m 5.69m 343.59

Ownership

Directors and executive officers, together 5.30%
Entities affiliated with Bain Capital Investors, LLC 37.50%
J.H. Whitney Equity Partners VII 18.40%
Nut Tree Capital Management, LP 5.70%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Aveanna Healthcare Holdings Inc. (AVAH) Latest News

27 Oct

Impact 3 · · Zacks

18 Oct

Impact 3 · · Simply Wall St.

17 Oct

Impact 4 · · Simply Wall St.

16 Oct

Impact 3 · · Zacks

14 Oct

Impact 3 · · Zacks

12 Oct

Impact 3 · · Zacks

9 Oct

Impact 3 · · Zacks

30 Sep

Impact 3 · · Zacks

4 Sep

Impact 3 ·

28 Aug

Impact 3 · · Barchart

26 Aug

Impact 3 ·

24 Aug

Impact 3 ·

21 Aug

Impact 4 ·
Impact 3 ·

20 Aug

Impact 4 · · The Motley Fool transcript

14 Aug

Impact 4 ·

13 Aug

Impact 4 ·
Impact 4 ·
Impact 3 · · Moby transcript
Impact 3 · · MarketBeat
Impact 3 ·
Impact 3 ·

10 Aug

Impact 3 ·

22 Jun

Impact 3 · · Zacks

2 Jun

Impact 4 · · MarketBeat
Impact 4 · · GlobeNewswire

28 May

Impact 3 · · GlobeNewswire

22 May

Impact 3 · · Simply Wall St.

15 May

Impact 3 · · Simply Wall St.

14 May

Impact 4 · · GuruFocus.com

AVAH metrics, ten years each

stockrow.com/AVAH · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com